Search all medical codes

Adverse effect of unspecified fibrinolysis-affecting drugs, sequela

ICD10CM code

Similar Codes


ICD10CM codes

T45.605S - Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.695S - Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.605D - Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.606S - Underdosing of unspecified fibrinolysis-affecting drugs, sequela
T45.605 - Adverse effect of unspecified fibrinolysis-affecting drugs
T45.604S - Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela
T45.605A - Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.603S - Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela
T45.694S - Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela
T45.615S - Adverse effect of thrombolytic drugs, sequela

HCPCS codes

G8969 - Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G8696 - Antithrombotic therapy prescribed at discharge
G8968 - Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
G8972 - One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
G9929 - Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardi
G9928 - Warfarin or another fda-approved anticoagulant not prescribed, reason not given
G8506 - Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb
J3246 - Injection, tirofiban hcl, 0.25 mg
G8935 - Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (
D9630 - OTHER DRUGS AND/OR MEDICAMENTS

CPT4 codes

85390 - Fibrinolysins or coagulopathy screen, interpretation and report
85410 - Fibrinolytic factors and inhibitors; alpha-2 antiplasmin
85397 - Coagulation and fibrinolysis, functional activity, not otherwise specified (eg, ADAMTS-13), each ana
85305 - Clotting inhibitors or anticoagulants; protein S, total
85366 - Fibrin(ogen) degradation (split) products (FDP) (FSP); paracoagulation
85415 - Fibrinolytic factors and inhibitors; plasminogen activator
85290 - Clotting; factor XIII (fibrin stabilizing)
85210 - Clotting; factor II, prothrombin, specific
85378 - Fibrin degradation products, D-dimer; qualitative or semiquantitative
85300 - Clotting inhibitors or anticoagulants; antithrombin III, activity